Difference between revisions of "Part:BBa K2549021"
Line 12: | Line 12: | ||
<!-- Add more about the biology of this part here --> | <!-- Add more about the biology of this part here --> | ||
===Biology=== | ===Biology=== | ||
− | |||
− | |||
− | |||
=====Clinical significance of anti-CD19===== | =====Clinical significance of anti-CD19===== | ||
Please refer to our basic [[Part:BBa_K2549005]] for more details. | Please refer to our basic [[Part:BBa_K2549005]] for more details. | ||
Line 26: | Line 23: | ||
Please refer to the original article for more details. | Please refer to the original article for more details. | ||
+ | ===Characterization=== | ||
+ | ====It works as we designed.==== | ||
+ | [[File:bestNotch.jpg|none|480px|thumb|'''Flow cytometry results of SynNotch receptors. surAg, surface antigens, which represent surface-expressed CD19 or surface-expressed EGFP, respectively. A EGFP-P2A circuit is placed downstream the SynNotch, which means they are in the same open reading framework.''']] | ||
+ | |||
+ | It is obvious that α CD19-mN1c-tTAA can be significantly activated by surface-expressed CD19. It also has the highest signal-to-noise ratio among all the SynNotch that we submitted. Besides, it has a relatively low wrong activation ratio which can be tolerated. Compared to other SynNotch cells, α CD19 SynNotch cells can be activated more readily by its antigens which means the activation ratio is far ahead than any other SynNotch receptors. '''Therefore, it becomes our team's favorite!''' | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display |
Revision as of 14:40, 17 October 2018
aCD19-mN1c-tTAA
This part is one of our SynNotch receptors, similar to the original published version[1]. It is our favorite. αCD19 (Part:BBa_K2549005) is used as the extracellular sensor module to receive the signal input from surface-expressed CD19. mN1c (Part:BBa_K2549006) is served as the transmembrane core domain of SynNotch, which is evident to have a low basal expression and a high activation efficiency. tTAA (Part:BBa_K2446057) is an improved tetracycline-controlled transactivator[2], which is cleaved after SynNotch activation and drives the expression of the amplifier. Besides, a CD8α signal peptide (Part:BBa_K2549044) and a Myc-tag (Part:BBa_K823036) are added to the N terminal of αCD19 (Part:BBa_K2549005) for membrane targeting and easy determination of surface expression.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 2493
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 534
Illegal SapI.rc site found at 1408
Biology
Clinical significance of anti-CD19
Please refer to our basic Part:BBa_K2549005 for more details.
SynNotch receptors function well in Morsut L et al 2016
Please refer to the original article for more details.
Characterization
It works as we designed.
It is obvious that α CD19-mN1c-tTAA can be significantly activated by surface-expressed CD19. It also has the highest signal-to-noise ratio among all the SynNotch that we submitted. Besides, it has a relatively low wrong activation ratio which can be tolerated. Compared to other SynNotch cells, α CD19 SynNotch cells can be activated more readily by its antigens which means the activation ratio is far ahead than any other SynNotch receptors. Therefore, it becomes our team's favorite!
References
- ↑ Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors. Morsut L, Roybal KT, Xiong X, ..., Thomson M, Lim WA. Cell, 2016 Feb;164(4):780-91 PMID: 26830878; DOI: 10.1016/j.cell.2016.01.012
- ↑ Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Urlinger S, Baron U, Thellmann M, ..., Bujard H, Hillen W. Proc Natl Acad Sci U S A, 2000 Jul;97(14):7963-8 PMID: 10859354